Consumer Affairs: Mark Cameron, associate professor at the School of Medicine, discussed the FDA’s recent approval of booster doses of Pfizer’s COVID vaccine for children between 12 and 15 years of age.

Medicine's Mark Cameron weighs in on FDA's decision to approve booster doses for 12- to 15-year-olds
MEDIA |
March 4, 2022
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF